Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04262869
Title Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

lung non-small cell carcinoma

Therapies

Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Paclitaxel

Durvalumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.